Science Explorer Back to mapMap
Discussion
Company · Mechelen · Belgium

Biocartis (Belgium)

biocartis.comROR OpenAlex
Research works
27
▼ 11% vs 2018-21
Citations
202
7.5 per fractional work
Top-10% rate
4.0%
all institutions 10.0%
Open access
34%
world 40%
International
46%
world 18%
Biocartis (Belgium)

Not ranked overall: Biocartis (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Biocartis (Belgium) work in?

In all years, 53% of research at Biocartis (Belgium) is in Health Sciences, 40% in Life Sciences. Its largest fields are Medicine (53%), Biochemistry, Genetics and Molecular Biology (33%), Immunology and Microbiology (6%). It does 1.9× the world's share of Life Sciences.

Health Sciences: 14 fractional works · 53.5% of its workMedicine: 14 fractional works · 53.2% of its workPathology and Forensic Medicine: 3 fractional works · 9.9% of its workOncology: 3 fractional works · 9.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 7.9% of its workInfectious Diseases: 2 fractional works · 6.9% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 6.3% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 4.9% of its workEpidemiology: 1 fractional works · 3.1% of its workSurgery: 0 fractional works · 1.9% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.1% of its workHepatology: 0 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workLife Sciences: 11 fractional works · 40.0% of its workBiochemistry, Genetics and Molecular Biology: 9 fractional works · 32.7% of its workMolecular Biology: 4 fractional works · 15.7% of its workCancer Research: 3 fractional works · 12.8% of its workBiophysics: 1 fractional works · 2.3% of its workGenetics: 0 fractional works · 1.0% of its workBiotechnology: 0 fractional works · 0.7% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 5.7% of its workVirology: 1 fractional works · 3.4% of its workImmunology: 0 fractional works · 1.9% of its workMicrobiology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 1.6% of its workInsect Science: 0 fractional works · 1.6% of its workPhysical Sciences: 1 fractional works · 5.1% of its workChemistry: 0 fractional works · 1.9% of its workOrganic Chemistry: 0 fractional works · 1.6% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 1.9% of its workInformation Systems: 0 fractional works · 1.9% of its workEngineering: 0 fractional works · 0.8% of its workElectrical and Electronic Engineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.6% of its workEcology: 0 fractional works · 0.6% of its workSocial Sciences: 0 fractional works · 1.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.4% of its workEconomics and Econometrics: 0 fractional works · 1.4% of its workALL ITS WORKBiocartis(Belgium)27fractional works, all years
Life Sciences40%Physical Sciences5%Health Sciences53%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Medicine1453.2%
    2. Nursing00.3%
    1. Biochemistry, Genetics and Molecular Biology932.7%
    2. Immunology and Microbiology25.7%
    3. Agricultural and Biological Sciences01.6%
    1. Chemistry01.9%
    2. Computer Science01.9%
    3. Engineering00.8%
    4. Environmental Science00.6%
    1. Economics, Econometrics and Finance01.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Biocartis (Belgium)?

Ranked on the quality score, Benoit Devogelaere, Tania Ivens and Evelien Rondelez lead among researchers whose main affiliation is Biocartis (Belgium).

  1. 1 Benoit Devogelaere Belgium · #1,875,794 worldwide 1.1k citations · 38 works
  2. 2 Tania Ivens Belgium · #2,033,263 worldwide 959 citations · 20 works
  3. 3 Evelien Rondelez Belgium · #4,671,687 worldwide 587 citations · 24 works
All ranked researchers at Biocartis (Belgium)

What are the most cited papers from Biocartis (Belgium)?

The most cited paper from Biocartis (Belgium) is "Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors" (Max S. Schreuer, Geert Meersseman, Sari Van Den Herrewegen et al., 2016), with 141 citations. Next come "Comparison of Pathogen DNA Isolation Methods from Large Volumes of Whole Blood to Improve Molecular Diagnosis of Bloodstream Infections" (88) and "BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System" (78).

Most cited papers
#PaperReleasedCitations
1 Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors Max S. Schreuer, Geert Meersseman, Sari Van Den Herrewegen et al. · Journal of Translational Medicine Open access 19 Apr 2016 141
2 Comparison of Pathogen DNA Isolation Methods from Large Volumes of Whole Blood to Improve Molecular Diagnosis of Bloodstream Infections Anne J. M. Loonen, Martine P. Bos, Bart Van Meerbergen et al. · PLoS ONE Open access 15 Aug 2013 88
3 BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System Filip Jankú et al. · Molecular Cancer Therapeutics 22 May 2016 78
4 BRAF mutation testing with a rapid, fully integrated molecular diagnostics system Filip Jankú et al. · Oncotarget Open access 27 Jul 2015 51
5 Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma Linea Cecilie Melchior, Morten Grauslund, Beatríz Bellosillo et al. · Experimental and Molecular Pathology 26 Sep 2015 48
All 52 most cited papers, with filters and sorting

Which keywords describe research at Biocartis (Belgium)?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Cancer Genomics, Mutational Signatures, Molecular Characterization, Hereditary Syndromes, Microsatellite Instability, Immune Response and Precision Medicine.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Targeted Therapy5▲ 82×2 topics
  2. Cancer Genomics3▲ 234×1 topic
  3. Mutational Signatures3▲ 234×1 topic
  4. Epidemiology3▲ 2.9×14 topics
  5. Molecular Characterization3▲ 59×2 topics
  6. Hereditary Syndromes3▲ 271×1 topic
  7. Microsatellite Instability3▲ 271×1 topic
  8. Immune Response2▲ 13×6 topics
  9. Precision Medicine2▲ 25×2 topics
  10. Antiretroviral Therapy2▲ 30×3 topics
  11. Chemotherapy2▲ 9.7×2 topics
  12. Deep Learning2▲ 3.1×3 topics
  13. Cetuximab2▲ 76×1 topic
  14. KRAS Mutations2▲ 188×1 topic
  15. Vaccine Development2▲ 20×4 topics
  16. Vaccine2▲ 14×5 topics
  17. Clinical Trials1▲ 8.3×3 topics
  18. Medical Imaging1▲ 19×2 topics
  19. ALK Inhibitors1▲ 88×1 topic
  20. EGFR Mutations1▲ 88×1 topic
  21. Gene Expression1▲ 8.1×3 topics
  22. Data Analysis1▲ 14×2 topics
  23. Normalization1▲ 62×2 topics
  24. COVID-191▲ 6.4×2 topics
  25. Immunotherapy1▲ 6.5×6 topics
  26. Machine Learning1▲ 1.97×3 topics
  27. Quantitative1▲ 34×1 topic
  28. Real-Time PCR1▲ 94×1 topic
  29. Chest X-Ray1▲ 149×1 topic
  30. Convolutional Neural Networks1▲ 8.9×1 topic

Which research topics does Biocartis (Belgium) publish most on?

By volume in 2022-now: Advanced Biosensing Techniques and Applications, Cell Image Analysis Techniques, Advanced Breast Cancer Therapies and Cancer Genomics and Diagnostics.

Advanced Biosensing Techniques and Applications: 0 fractional worksCell Image Analysis Techniques: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksLung Cancer Treatments and Mutations: 0 fractional worksMolecular Biology Techni…0Molecular Biology Techniques and Applications: 0 fractional worksCAR-T cell therapy research: 0 fractional worksNeutrophil, Myeloperoxidase and Oxidative Mechanisms: 0 fractional worksPI3K/AKT/mTOR signaling in cancer: 0 fractional worksBlood disorders and treatments: 0 fractional works
Molecular BiologyBiophysicsPulmonary and Respiratory MedicineCancer Research3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
  2. 2 Cell Image Analysis Techniques Biophysics 0 works
  3. 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 0 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  6. 6 Molecular Biology Techniques and Applications Molecular Biology 0 works
  7. 7 CAR-T cell therapy research Oncology 0 works
  8. 8 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 0 works
  9. 9 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
  10. 10 Blood disorders and treatments Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.6%not open66.4%

World: 40% of research is openly available.

with international co-authors45.6%domestic only54.4%

World: 18% is written across borders.

How has Biocartis (Belgium)'s research output changed?

Output in 2022-2025 was 11% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Biocartis (Belgium) as a percentage of every work published that year, 0.000024% in 2024.

still counting0.00010%0.00020%Biocartis (Belgium)0.0000085% in 202520102020

Fractional works of Biocartis (Belgium) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Mechelen

All research institutions in Mechelen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Biocartis (Belgium). Posts are plain text and can be reported.